Sales rise 85.02% to Rs 535.58 crore
Net Loss of Omaxe reported to Rs 145.05 crore in the quarter ended March 2024 as against net loss of Rs 105.47 crore during the previous quarter ended March 2023. Sales rose 85.02% to Rs 535.58 crore in the quarter ended March 2024 as against Rs 289.47 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 402.60 crore in the year ended March 2024 as against net loss of Rs 347.91 crore during the previous year ended March 2023. Sales rose 108.75% to Rs 1614.32 crore in the year ended March 2024 as against Rs 773.33 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales535.58289.47 85 1614.32773.33 109 OPM %-27.32-37.82 --21.26-39.22 - PBDT-177.63-126.55 -40 -452.81-391.40 -16 PBT-191.23-142.72 -34 -507.07-456.77 -11 NP-145.05-105.47 -38 -402.60-347.91 -16
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
